Thomas N. Krausz to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Thomas N. Krausz has written about Antineoplastic Agents, Immunological.
Connection Strength
0.076
-
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. Clin Cancer Res. 2020 12 15; 26(24):6437-6444.
Score: 0.040
-
Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays. Hum Pathol. 2019 05; 87:11-17.
Score: 0.036